ARCHIVES

In Brief: ACS Asks Removal Of Dollar Authorization Levels; FDA May Overrule Advisors On Estramustine

This article is from The Cancer Letter archive.

Vol. 05 No. 47 | November 23, 1979

Download PDF Visit The Full Archive

Related Articles

In Brief: FDA Oncology Div. Director Burke To Leave; Reed Is Branch Chief; NCAB Blasts Tobacco

November 4, 1994

Dana-Farber And Merck To Collaborate On Therapeutics.

February 15, 2008

Pathology In Operating Suite Cuts Need for More Surgery

February 24, 2012

FDA Approvals: Lymphoseek Label Updated to Include Head and Neck SCC

June 27, 2014

NIH Funding Opportunity: Outstanding Investigator Award In Cancer Research Available

June 11, 2014

Berlin, DeVita Differ On Use Of L-PAM

November 8, 1974